Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer – the prevalence and location of bone- and lymph node metastases

HIGHLIGHTS

• who: Erik Rud from the Division of and Nuclear Medicine, University have published the research work: Validating the screening criteria for bone metastases in treatment-nau00efve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases, in the Journal: (JOURNAL)
• what: The authors aimed to validate the screening criteria for metastases in patients with treatment-nau00efve cancer. Using an abbreviated MRI protocol of the lumbar column and pelvis, this study demonstrated bone metastases in 7% of those eligible for a metastatic workup according to the EAU guidelines.
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.